XPO cuts target price to $230 from $250
XPO•Wells Fargo cut its target price for XPO to $230 from $250.
Related News
Neurocrine Biosciences launches interactive educational resources to support clinical learning in classic congenital adrenal hyperplasia
NBIX•
Lincoln National declares quarterly Series D preferred dividend of $562.50 per share
LNC•
Nasdaq set for sharp drop as Amazon, Intel amplify AI spending worries
QQQ•
Viatris launches tender offer to acquire Pacira BioSciences for $36.50 a share
PCRX•
IRadimed Q3 EPS USD 0.51
IRMD•